LON:CLL Cello Health plc (CLL.L) (CLL) Share Price, News & Analysis → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free CLL Stock Alerts GBX 161 0.00 (0.00%) (As of 08/11/2020) Add Compare Share Share Today's Range 161▼ 16150-Day Range 161▼ 16152-Week Range 100▼ 165VolumeN/AAverage Volume453,244 shsMarket Capitalization£178.84 millionP/E RatioN/ADividend Yield1.24%Price TargetN/A Stock AnalysisStock Analysis Get Cello Health plc (CLL.L) alerts: Email Address Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. About Cello Health plc (CLL.L) Stock (LON:CLL)Cello Health plc, together with its subsidiaries, provides marketing services in the United Kingdom, Rest of Europe, the United States, and internationally. It operates in two segments, Cello Health and Cello Signal. The Cello Health segment offers market research, consulting, and communications services principally to the pharmaceutical and healthcare clients. The Cello Signal segment provides market research and direct communications services principally to consumer-facing clients. Cello Health plc was incorporated in 2004 and is headquartered in London, the United Kingdom.Read More CLL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CLL Stock News HeadlinesApril 9, 2024 | forbes.comBest Virtual Therapy Services of 2024February 15, 2024 | forbes.comBest Gay Dating Sites Of 2024May 4, 2024 | Stansberry Research (Ad)Global crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...February 6, 2024 | health.usnews.comDr. Patrick L. CelloJanuary 30, 2024 | morningstar.comPrimary Health Properties PLCJanuary 5, 2024 | uk.investing.comProbiotix Health PLC (X90)December 22, 2023 | forbes.comBest Low-Carb Diet Meal Delivery Plans of 2023December 15, 2023 | health.usnews.comJessica L. JohnstonMay 4, 2024 | Stansberry Research (Ad)Global crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...December 2, 2023 | forbes.comHow Much Do Invisible Braces CostNovember 23, 2023 | forbes.comBest Dating Sites For Singles Over 50 in 2023November 1, 2023 | msn.comCello World IPO Subscribed 38% On Day 1October 27, 2023 | bbc.co.ukThe Bee CelloOctober 18, 2023 | msn.com8 Best Cellos for Beginners of 2023June 23, 2023 | finance.yahoo.comLTG.L - Learning Technologies Group plcJune 13, 2023 | uk.finance.yahoo.comPFD.L - Premier Foods plcMay 12, 2023 | investing.comTrellus Health PLC (TRLST)May 10, 2023 | investing.comRutherford Health PLC (RUTH)April 8, 2023 | morningstar.comOne Health Group Plc Ordinary SharesMarch 26, 2023 | finance.yahoo.comQ4 2022 Exscientia PLC Earnings CallMarch 26, 2023 | seekingalpha.comAccenture plc 2023 Q2 - Results - Earnings Call PresentationJanuary 29, 2023 | seekingalpha.comWizz Air Holdings Plc 2023 Q3 - Results - Earnings Call PresentationNovember 3, 2022 | markets.businessinsider.comLoxo@Lilly Announces Details of Presentations at the 2022 American Society of Hematology Annual MeetingSeptember 30, 2022 | thetimes.co.ukAbel Selaocoe: ‘The cello was a key to a life out of the township’September 7, 2022 | msn.comCello teacher accused of sexually assaulting studentSee More Headlines Receive CLL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cello Health plc (CLL.L) and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorBusiness Services Industry Marketing Services Sub-IndustryN/A Current SymbolLON:CLL CUSIPN/A CIKN/A Webwww.cellogroup.com Phone+44-20-78128460FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio14.72 Current Ratio1.15 Quick Ratio1.11 Sales & Book Value Annual Sales£166.77 million Price / Sales1.07 Cash FlowGBX 8 per share Price / Cash Flow20.13 Book ValueGBX 77.60 per share Price / Book2.07Miscellaneous Outstanding Shares111,080,000Free FloatN/AMarket Cap£178.84 million OptionableNot Optionable BetaN/A 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Mark Scott (Age 53)CEO & Exec. Director Mr. Mark Bentley (Age 48)Group Fin. Director, Company Sec. & Exec. Director Mr. Stephen HighleyGroup COO & DirectorMr. Owen WilliamsManaging PartnerMr. Vincent NolanManaging PartnerKey CompetitorsStatPro GroupLON:SOGEasyhotelLON:EZHiEnergizerLON:IBPOManx TelecomLON:MANXCastleton TechnologyLON:CTPView All Competitors CLL Stock Analysis - Frequently Asked Questions How have CLL shares performed in 2024? Cello Health plc (CLL.L)'s stock was trading at GBX 161 at the beginning of 2024. Since then, CLL stock has increased by 0.0% and is now trading at GBX 161. View the best growth stocks for 2024 here. Is Cello Health plc (CLL.L) a good dividend stock? Cello Health plc (CLL.L) (LON:CLL) pays an annual dividend of GBX 2 per share and currently has a dividend yield of 1.34%. Read our dividend analysis for CLL. What other stocks do shareholders of Cello Health plc (CLL.L) own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cello Health plc (CLL.L) investors own include Lloyds Banking Group (LLOY), Sirius Minerals (SXX), Saga (SAGA), QinetiQ Group (QQ), (OPTR) (OPTR), Modern Water plc (MWG.L) (MWG), IGas Energy (IGAS), 1984318 (IAP.L) (IAP), Gilead Sciences (GILD) and easyJet (EZJ). How do I buy shares of Cello Health plc (CLL.L)? Shares of CLL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:CLL) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024AltimetryBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe only AI company you should be looking atBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cello Health plc (CLL.L) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.